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narians and nonagenarians when patients are classified as
“elderly.”
Our series has a few limitations. The first pertains to
selection bias. There may have been patients deemed too
infirm to tolerate an operation who were treated nonopera-
tively. Data were not collected on nonoperatively treated
patients or their mortality or limb salvage status.
Another limitation was the lack of data on preoperative
ambulatory and independent living status, which are two
factors that are strong predictors of survival after peripheral
revascularization.2,7 Our database also did not keep records
of postoperative ambulation and quality of life status; we do
not know if any of the surviving 90 patients returned to
independent living.
There has been a nationwide trend toward percutane-
ous intervention for peripheral vascular disease, but our
series did not compare percutaneous intervention with
open procedures in the90 group.Our peripheral stenting
database was initiated in 1999 and up to 2007, and in that
time 1085 peripheral stents were placed. Septuagenarians
accounted for 314 (28.9%) and octogenarians accounted
for 187 (17.2%) peripheral stent procedures. Nonagenari-
ans accounted for nine lower extremity peripheral stents,
with one periprocedural cardiac-related death. Percutane-
ous intervention may offer a less invasive alternative to an
open procedure; however, 1-year mortality rates remain
significantly elevated in the elderly population in these
series.11,12 In accordance with the population changes, our
group has experienced an increase in the number of open
revascularization procedures in the nonagenarian popula-
tion. In light of these new mortality findings, our manage-
ment strategy is evolving toward using more aggressive
percutaneous methods or even nonoperative treatment.
CONCLUSIONS
Our series demonstrates that peripheral revasculariza-
tion can be performed with good patency and limb salvage
rates in nonagenarians, but with a significantly increased
mortality rate. These findings may temper the enthusiasm
for an aggressive approach to limb salvage in the elderly
population and also may have created a distinction between
octogenarians and nonagenarians when classifying patients
as elderly.
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Dr Brian Nolan (Lebanon, NH). I think your question is an
interesting one. The most pertinent finding, in my opinion, was
that nearly half of the patients over age 90 don’t survive 1 year
following major lower extremity revascularization. This begs the
question whether there is value in doing it and how do you select
those patients to whom it is of value? So, the question I have is,
have you analyzed your data using multivariate regression topatient selection? As a follow-up to that, have you looked at any
other age cohorts, like age greater than 80?
Finally, I think in your paper you point out that you reviewed
your entire revascularization experience, including claudicants, of
which therewere significantlymore claudicants in the age90group.
If you controlled for claudication, are your findings still significant?
Dr Jeffrey Hnath. We did not specifically use a multivariate
analysis study, but you bring up an interesting point, and we will
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further analysis. We did not specifically look at the 80-year-old or
even the 70-year-old patient data; we felt that the octogenarian
population had previously been studied.
There were about 20% more claudicants in the 90 popula-
tion in our study, and only one patient 90 received a bypass for
claudication. If we segregate by indication we may find a slight
change in the mortality rate.
Dr Ruth Bush (Temple, Tex). In your Kaplan-Meier curve,
you showed a highmortality rate, which you would expect for folks
over 90, but you didn’t include the number at risk or the confi-
dence interval bars on your patency rate. I think just my comment
would be that that would be important to include in the manu-
script, because I suspect those numbers trickle off quite a bit.
Dr Erica Mitchell (Portland, Ore). Did you look at the
30-day and 1-year mortality rates of 90-year-olds who underwent
amputation, and if so, were they different to that after bypass?
Dr Hnath. We did review our amputation patients, and
actually, the 30-day mortality rate in our above knee amputations
is anywhere from 30% to 45%.
Dr Lee Goldstein (New York, NY). In the last decade you
reported almost 5500 bypasses, which works out to almost 1.5
bypasses every day. I would imagine that volume in the nonage-
narian population in the last few years has significantly decreasedI think the patients that have gotten to be in their 90s would
have a different form of vascular disease if they have gotten that far.
With your patency rates being especially better in that population,
have you thought about comparing, or at least breaking down,
your time frame into an earlier vs a later period and looking at the
impact of endovascular therapies on these older patients?
Dr Hnath. We looked at our endovascular numbers and we
had a surprisingly low number of nonagenarians. We performed a
percutaneous intervention on nine patients in that time span, with
only one mortality. If we get more numbers, then maybe we can
look into it a little further.
Dr Jim Watson (Seattle, Wash). This study provides some
data for what’s been my practice for a long time, which is to
minimize interventions in the older population while avoiding
amputation. As you point out, amputations are devastating in older
patients. However, I have occasionally tolerated small ulcers or
mild gangrene in an elderly patient without intervening, as long as
it doesn’t progress. Some of these problems have healed, and some
patients have died of other causes without treatment of their
ischemia. Obviously, some lesions need intervention. But any
intervention on the elderly carries significant risk of complications,
and whatever we can do to avoid amputation and keep them out of
the hospital is what we should focus on.
Dr Hnath. I agree. We need to be selective about how we
with the advent of aggressive endovascular interventions. treat this population.
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